Also trades as: TSUSF (OTC) · $vol 0M

¥2,061.00 ($13.06)

-35.00 (-1.67%)

Weekly Expected Move ±3.5%

¥1916 ¥1989 ¥2061 ¥2133 ¥2206

JPX · Healthcare · Medical - Pharmaceuticals · Tech Score Sell · Power 28 · ¥933.8B mcap · 203M float · 0.933% daily turnover

Revenue

$1.07T +4.3% ▲

5Y CAGR: +5.0%

Gross Profit

$326.4B +4.5% ▲

5Y CAGR: +6.0%

Operating Income

$48.0B +1.9% ▲

5Y CAGR: +1.3%

Net Income

$21.8B +0.3% ▲

5Y CAGR: -4.8%

EPS (Diluted)

$448.23 +401.1% ▲

5Y CAGR: -4.9%

EBITDA

$57.4B -0.7% ▼

5Y CAGR: +0.3%

View Full Income Statement

Line Item	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$919.3B	$915.7B	$970.1B	$1.03T	$1.07T
YoY Growth	+9.3%	-0.4%	+5.9%	+5.9%	+4.3%
Cost of Revenue	$652.6B	$644.2B	$676.7B	$715.2B	$745.3B
Gross Profit	$266.7B	$271.5B	$293.4B	$312.3B	$326.4B
Gross Margin	29.0%	29.6%	30.2%	30.4%	30.5%
R&D Expenses	$0	$0	$0	$0	$0
SG&A Expenses	$218.0B	$230.9B	$247.8B	$263.1B	$278.4B
Operating Expenses	$218.3B	$230.9B	$247.8B	$263.1B	$278.4B
Operating Income	$48.4B	$40.6B	$45.6B	$47.2B	$48.0B
Operating Margin	5.3%	4.4%	4.7%	4.6%	4.5%
Interest Expense	$634M	$802M	$1.3B	$1.6B	$1.8B
Income Before Tax	$46.0B	$37.6B	$43.5B	$38.2B	$36.0B
Tax Expense	$16.5B	$13.2B	$14.8B	$13.8B	$12.4B
Net Income	$26.3B	$21.4B	$25.3B	$21.7B	$21.8B
Net Margin	2.9%	2.3%	2.6%	2.1%	2.0%
EPS (Diluted)	$107.98	$87.84	$103.70	$89.45	$448.23
EBITDA	$60.0B	$53.1B	$61.3B	$57.8B	$57.4B
Shares Outstanding	49M	49M	49M	49M	49M

Line Item	FY2024 Q2	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1
Revenue	$273.4B	$263.1B	$309.3B	$272.5B	$285.3B	$275.6B	$617.2B	$636.9B
Cost of Revenue	$191.0B	$182.8B	$214.4B	$190.1B	$198.9B	$193.6B	$424.0B	$445.1B
Gross Profit	$82.4B	$80.3B	$94.9B	$82.4B	$86.4B	$82.0B	$193.2B	$191.7B
Gross Margin	30.2%	30.5%	30.7%	30.2%	30.3%	29.8%	31.3%	30.1%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$67.3B	$68.8B	$83.6B	$69.9B	$70.4B	$69.8B	$170.8B	$0
Operating Expenses	$67.3B	$68.8B	$83.8B	$69.9B	$70.4B	$69.8B	$170.8B	$167.5B
Operating Income	$15.1B	$11.5B	$11.1B	$12.5B	$16.0B	$12.2B	$22.4B	$24.2B
Operating Margin	5.5%	4.4%	3.6%	4.6%	5.6%	4.4%	3.6%	3.8%
Interest Expense	$410M	$422M	$552M	$499M	$518M	$556M	$937M	$1.2B
Income Before Tax	$15.0B	-$693M	$13.9B	$18.7B	$15.1B	$11.2B	$21.3B	$25.2B
Tax Expense	$5.3B	$153M	$4.4B	$6.7B	$5.1B	$4.0B	$5.1B	$11.1B
Net Income	$9.0B	-$803M	$8.8B	$11.1B	$9.3B	$6.6B	$15.7B	$13.5B
Net Margin	3.3%	-0.3%	2.8%	4.1%	3.2%	2.4%	2.5%	2.1%
EPS (Diluted)	$183.97	$-16.50	$180.49	$227.47	$37.83	$26.98	$33.78	$29.70
EBITDA	$19.6B	$4.5B	$17.4B	$23.9B	$20.5B	$17.2B	$38.3B	$39.6B
Shares Outstanding	49M	49M	49M	49M	245M	245M	465M	454M

3391.T JPX